These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6178950)

  • 21. Biological and molecular aspects on herpes simplex virus latency.
    Lycke E
    Scand J Infect Dis Suppl; 1990; 69():113-9. PubMed ID: 2175937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice.
    Clements GB; Stow ND
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2501-6. PubMed ID: 2550578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection by complementation of defective or uninducible (herpes simplex type 1) virus genomes latent in human ganglia.
    Brown SM; Subak-Sharpe JH; Warren KG; Wroblewska Z; Koprowski H
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2364-8. PubMed ID: 221922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress of diagnostic methods for antigens and antibody testing of type 1 and 2 herpes simplex viruses].
    Kurata T
    Nihon Rinsho; 1989 Feb; 47(2):350-5. PubMed ID: 2542656
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistence of herpes simplex virus (HSV) infection in ganglia and peripheral tissues of guinea pigs.
    Scriba M
    Med Microbiol Immunol; 1981; 169(2):91-6. PubMed ID: 6261108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical consequences of persistent viral infection.
    Southern P; Oldstone MB
    N Engl J Med; 1986 Feb; 314(6):359-67. PubMed ID: 3511377
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.
    Schmidt DS; Eis-Hübinger AM; Schneweis KE
    Arch Virol; 1993; 133(1-2):179-87. PubMed ID: 8240008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Herpes simplex virus and glomerulonephritis].
    Filimonova RG; Nevraeva EG; Posevaia TA
    Ter Arkh; 1988; 60(6):88-91. PubMed ID: 2849813
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential accumulation of herpes simplex virus type 1 latency-associated transcripts in sensory and autonomic ganglia.
    Rødahl E; Stevens JG
    Virology; 1992 Jul; 189(1):385-8. PubMed ID: 1604823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcripts associated with herpes simplex virus latency.
    Stevens JG
    Adv Exp Med Biol; 1990; 278():199-204. PubMed ID: 1963035
    [No Abstract]   [Full Text] [Related]  

  • 33. Herpes simplex virus latency: adaptation to the peripheral nervous system. II.
    Price RW
    Cancer Invest; 1985; 3(4):389-403. PubMed ID: 2992726
    [No Abstract]   [Full Text] [Related]  

  • 34. Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis.
    Vestergaard BF
    Rev Infect Dis; 1980; 2(6):899-913. PubMed ID: 6164087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avian infectious bronchitis: characteristics of the virus and antigenic types.
    Cunningham CH
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):522-3. PubMed ID: 47725
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic analysis of the two Herpes simplex type viruses].
    Schneweis KE
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):95-7. PubMed ID: 4145642
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells.
    McClung H; Seth P; Rawls WE
    Am J Epidemiol; 1976 Aug; 104(2):181-91. PubMed ID: 60057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccine therapy of virus diseases].
    Nihon Rinsho; 1990 Aug; 48 Suppl():618-763. PubMed ID: 1700170
    [No Abstract]   [Full Text] [Related]  

  • 39. Persistent, slow and latent viral infections.
    Stroop WG; Baringer JR
    Prog Med Virol; 1982; 28():1-43. PubMed ID: 6283598
    [No Abstract]   [Full Text] [Related]  

  • 40. Virus-cell interactions: a classification for virus-caused human disease.
    Robb JA
    Prog Med Virol; 1977; 23():51-61. PubMed ID: 339275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.